Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

Then, Now, and Tomorrow: Evolving the Management of Diabetic Retinopathy (DR) and the Role of the Optometrist – Bakersfield

By: Nathan Steinle, MD

This course has expired. You can still review the content but course credit is no longer available.

In Person Credits: 2

Expiration Date: Friday, May 31, 2019
Release Date: May 7, 2019

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the increasing prevalence of diabetes and diabetic retinopathy.
  • Identify which patients need to be screened earlier based on their disease state.
  • Explain to patients the need for early referral to retina specialists.
  • Summarize how diabetic eye disease may affect patients with visually significant cataract and initiate appropriate treatment for these patients.
  • Discuss how imaging devices may be able to provide earlier diagnosis of disease or disease progression.

Accreditation and Designation Statement

This course is COPE approved for 2.0 hours of CE Credit for Optometrists:

COPE Course ID 61763-PS.

COPE Activity ID 117128.


Faculty and Disclosures

The following faculty/staff members have the following financial relationships with commercial interests:

Nathan Steinle, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences; Genentech; Notal Vision; and Vortex Surgery. Advisory Board/Speaker’s Bureau: Genentech; and Regeneron Pharmaceuticals, Inc. Grant/Research Support: Carl Zeiss Meditec;  Genentech; and Regeneron Pharmaceuticals, Inc.

Editorial Support Disclosures
Erin K. Fletcher, MIT, director of compliance and education, Evolve and Susan Gallagher-Pecha, director of client services and project management, Evolve, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.



The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals, Inc. or Carl Zeiss Meditec Inc.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.